Dear Friends and Colleagues,
The World Allergy Organization is truly unique in that it is the only global federation for allergy, asthma and clinical immunology. As an umbrella organization, WAO has worldwide reach through its 97 member societies made up of regional and national allergy, asthma and clinical immunology societies covering all regions.
WAO’s member societies are making a positive impact on the physicians and patients in their home countries in the diagnosis and treatment of allergic diseases and asthma; they are truly changing lives for the better on a daily basis... >> Read More
Inside the Issue
- Meet Your WAO Leaders: Prof Motohiro Ebisawa, WAO Secretary-General
- Ask the World Experts
- Collaborative on Severe Asthma - World Allergy Forum
- Call for Applications - Web Regional Editor (Asia-Pacific)
- Junior Member Group Update
- Call for Applications: WAO Centers of Excellence
- WAO Social Media
- WAO Journal Articles
WAO International Scientific Conference 2016
WISC 2016 Registration and Abstract Submission is Now Open
To register for WISC 2016, click here.
To submit an abstract to be considered for inclusion in the WISC 2016 Scientific Program, click here.
Meet Your WAO Leaders
Motohiro Ebisawa, MD, PhD
Secretary-General, World Allergy Organization
Department of Allergy, Clinical Research Center for Allergology and Rheumatology,
Sagamihara National Hospital, Sagamihara, Japan
Member Society: Japanese Society of Allergology (JSA)
What inspired you to become more involved in WAO?
In 2013, I got involved in the preparation of World Allergy Week. I mainly contributed as the Chair of Communication Committee. It is a great pleasure to communicate with and get to know people throughout the world.
What would you like to share about the work of your national member society?
In 2014, we published the JSA anaphylaxis guideline, adopting the WAO anaphylaxis guideline. We try to disseminate the anaphylaxis guideline by giving lectures at other medical societies’ annual meetings. We have published several guidelines in the field of allergy in our official journal of Allergology International.
What is one of your current special interests in the field of allergy/immunology?
Our department is the number one facility with the most food allergy cases in the world. We see a total of a few thousand food allergy patients and perform 16 to 20 oral food challenges a day. Our main focus is always for patients and not research. Since I moved to our institute, this policy has never changed. To find the best way to control or cure food allergy with anaphylaxis is our hot topic right now.
Do you have any recent publications to share?
New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies.
Natural history of immediate-type hen's egg allergy in Japanese children.
Mast Cell Activation: Does mast cell activation and release occur in non-atopic food intolerance? What is the evidence, for and against?
Are you curious to read what the experts have to say on this question? Click here to read their answers.
To pose educational, scientific or medical questions about allergy, asthma and clinical immunology to WAO international experts, click here if you are a physician. Find a growing list of answered questions here.
World Allergy Forum - Emerging Anti-Cytokine Therapies in Severe Asthma
Internationally known speakers on severe asthma presented to a full hall of delegates at the annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) on 14 June 2016, at the Reed Messe Wien Congress Center in Vienna, Austria.
Prof. Mario Sanchez Borges, President of the World Allergy Organization, and Prof. Antonella Muraro, President of the EAACI, were Chairpersons of the symposium entitled, “Emerging Anti-Cytokine Therapies in Severe Asthma”. The forum was an initiative of the WAO Collaborative on Severe Asthma (COSA).
Dr. Thomas Casale spoke on “Cytokine Families and Receptors as Targets for Treatment in Severe Asthma”. Dr. Sally Wenzel spoke on “Cytokine Disruptive Therapies in Severe Asthma”, and Dr. William Busse spoke on “Eosinophilic Directed Therapies in Severe Asthma”.
Thank you to the World Allergy Forum speakers for sharing your time and expertise on this important topic in allergy/immunology medicine.
Production and distribution of this symposium was sponsored through an independent education grant from Teva Pharmaceuticals.
Regional Editor (Asia-Pacific), WAO Web Editorial Board
The World Allergy Organization (WAO) Web Editorial Board is accepting applications and nominations for Regional Editor for the Asia-Pacific region. The newly appointed Regional Editor will help promote WAO’s mission and website at every opportunity to increase use of the site and contributions, to oversee online projects, and to make other contributions to the WAO website. Candidates must be practicing allergists/immunologists and individual members of a WAO Member Society in the Asia-Pacific region with the ability to edit educational and scientific content for the web. For more information, please contact the WAO Secretariat by email. The deadline for applications is 30 June 2016.
Check out this month’s Junior Member Group News by WAO Junior Member, Prof Alexei Gonzalez, on the 7th Drug Hypersensitivity Meeting in Malaga, Spain. We greatly thank Prof Alexei Gonzalez for his contribution to this month’s WAO Junior Members News.
How would you like your organization to have a rich and lasting impact on the field of allergy/immunology? Submit your application for a chance to become a WAO Center of Excellence by 30 September 2016.
For more information and to submit an application, click here.
WAO on Twitter
WAO would like to thank its followers: WAO now has over 3,400 followers on Twitter!
Join them on WAO’s Twitter. WAO will bring you up-to-date information about current news and events of interest to allergists and immunologists. You will also get updates on future meetings, scientific content, and what is new at www.worldallergy.org.
And remember to visit our other social media sites!
Editor's Choice Literature Review
Allergen-associated immunomodulators: modifying allergy outcome
New Drugs and Targets for Asthma and COPD
What's New in Small Airways Research
Small-airway obstruction, assessed based on FEF25-75, contributes to long-term persistence of asthma and poor outcomes
What's New in Severe Asthma Research
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high dose inhaled corticosteroids plus a long-acting β2 agonist
Retrospective cohort analysis of healthcare claims in the United States characterizing asthma exacerbations in paediatric patients View Article
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D View Article